Meritage Portfolio Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $4.92M | Buy |
91,145
+84,761
| +1,328% | +$4.08M | 0.33% | 90 |
|
|
2025
Q3 | $288K | Sell |
6,384
-66
| -1% | -$3.08K | 0.02% | 285 |
|
|
2025
Q2 | $299K | Sell |
6,450
-99,496
| -94% | -$4.88M | 0.02% | 286 |
|
|
2025
Q1 | $6.46M | Sell |
105,946
-480
| -0.5% | -$28K | 0.43% | 68 |
|
|
2024
Q4 | $6.02M | Sell |
106,426
-1,838
| -2% | -$103K | 0.37% | 68 |
|
|
2024
Q3 | $5.6M | Buy |
108,264
+102,782
| +1,875% | +$4.82M | 0.34% | 89 |
|
|
2024
Q2 | $228K | Sell |
5,482
-46
| -0.8% | -$2.06K | 0.01% | 313 |
|
|
2024
Q1 | $300K | Sell |
5,528
-9,766
| -64% | -$497K | 0.02% | 297 |
|
|
2023
Q4 | $785K | Sell |
15,294
-53,868
| -78% | -$2.83M | 0.05% | 212 |
|
|
2023
Q3 | $4.01M | Sell |
69,162
-655
| -0.9% | -$40.1K | 0.3% | 112 |
|
|
2023
Q2 | $4.46M | Buy |
69,817
+2,126
| +3% | +$143K | 0.32% | 109 |
|
|
2023
Q1 | $4.69M | Buy |
67,691
+27,776
| +70% | +$1.96M | 0.35% | 99 |
|
|
2022
Q4 | $2.87M | Buy |
39,915
+1,288
| +3% | +$97.1K | 0.22% | 146 |
|
|
2022
Q3 | $2.75M | Buy |
38,627
+1,916
| +5% | +$139K | 0.23% | 128 |
|
|
2022
Q2 | $2.83M | Sell |
36,711
-43,371
| -54% | -$3.3M | 0.22% | 134 |
|
|
2022
Q1 | $5.85M | Buy |
80,082
+1,022
| +1% | +$68.6K | 0.36% | 79 |
|
|
2021
Q4 | $4.93M | Buy |
79,060
+24,009
| +44% | +$1.41M | 0.28% | 105 |
|
|
2021
Q3 | $3.26M | Sell |
55,051
-136
| -0.2% | -$8.96K | 0.2% | 127 |
|
|
2021
Q2 | $3.69M | Buy |
55,187
+274
| +0.5% | +$17.9K | 0.22% | 133 |
|
|
2021
Q1 | $3.47M | Buy |
54,913
+11,619
| +27% | +$723K | 0.23% | 131 |
|
|
2020
Q4 | $2.69M | Buy |
43,294
+1,971
| +5% | +$121K | 0.2% | 145 |
|
|
2020
Q3 | $2.49M | Sell |
41,323
-3,067
| -7% | -$185K | 0.22% | 121 |
|
|
2020
Q2 | $2.61M | Sell |
44,390
-4,225
| -9% | -$253K | 0.25% | 119 |
|
|
2020
Q1 | $2.71M | Sell |
48,615
-29,044
| -37% | -$1.78M | 0.37% | 80 |
|
|
2019
Q4 | $4.99M | Sell |
77,659
-28,144
| -27% | -$1.61M | 0.44% | 63 |
|
|
2019
Q3 | $5.37M | Buy |
105,803
+2,107
| +2% | +$99K | 0.51% | 53 |
|
|
2019
Q2 | $4.7M | Buy |
103,696
+42,058
| +68% | +$1.96M | 0.48% | 71 |
|
|
2019
Q1 | $2.94M | Buy |
+61,638
| New | +$3.07M | 0.3% | 130 |
|
|
2018
Q4 | – | Sell |
-115,291
| Closed | -$7.16M | – | 175 |
|
|
2018
Q3 | $7.16M | Sell |
115,291
-1,603
| -1% | -$95.1K | 0.66% | 37 |
|
|
2018
Q2 | $6.47M | Buy |
116,894
+22,006
| +23% | +$1.19M | 0.63% | 44 |
|
|
2018
Q1 | $6M | Sell |
94,888
-405
| -0.4% | -$26.1K | 0.58% | 61 |
|
|
2017
Q4 | $5.84M | Buy |
+95,293
| New | +$5.96M | 0.56% | 74 |
|
Other funds holding BMY
Meritage Portfolio Management's BMY Position: Q4 2025 in Review
Meritage Portfolio Management increased its Bristol-Myers Squibb (BMY) stake by 1,328% in Q4 2025, buying an estimated $4.08M and bringing the position to 91,145 shares worth $4.92M. The position accounts for 0.33% of the portfolio, ranked #90.
Meritage Portfolio Management first reported a position in BMY in Q4 2017 and has held it in 32 quarters since. The position peaked at $7.16M in Q3 2018. 2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Meritage Portfolio Management held 91,145 shares of Bristol-Myers Squibb worth $4.92M as of Q4 2025.
- Meritage Portfolio Management bought 84,761 Bristol-Myers Squibb shares in Q4 2025, an estimated $4.08M.
- Bristol-Myers Squibb made up 0.33% of Meritage Portfolio Management's portfolio in Q4 2025, its #90 holding.
- Meritage Portfolio Management first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 32 quarters since.
- Meritage Portfolio Management's Bristol-Myers Squibb position peaked at $7.16M in Q3 2018.
- 2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Meritage Portfolio Management's 13F filing for Q4 2025, filed 27 Jan 2026.